Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-021611

CEO and President gave up 125 shares (to pay taxes)

  • CEO and President acquired 510 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KLEMP WALTER V · CEO and President

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-20 Exercise or conversion : show line 1 in the form +150 30,765 D
2026-06-20 Shares withheld for taxes : show line 2 in the form −37 $2.88 $107 30,728 D
2026-06-22 Exercise or conversion : show line 3 in the form +360 31,088 D
2026-06-22 Shares withheld for taxes : show line 4 in the form −88 $3.12 $275 31,007 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-20 Exercise or conversion : show line 5 in the form Restricted Stock Units −150 326,696 D
2026-06-22 Exercise or conversion : show line 6 in the form Restricted Stock Units −360 326,336 D
Loading xslF345X06/rdgdoc.xml…